Literature DB >> 16534887

Detection of PERV by polymerase chain reaction and its safety in bioartificial liver support system.

Hai-Hui Wang1, Ying-Jie Wang, Hong-Ling Liu, Jun Liu, Yan-Ping Huang, Hai-Tao Guo, Yu-Ming Wang.   

Abstract

AIM: To establish a method detecting porcine endogenous retrovirus (PERV) in China experimental minipigs and to evaluate the safety of PERV in three individuals treated with bioartificial liver support systems based on porcine hepatocytes.
METHODS: Porcine hepatocytes were isolated with two-stage perfusion method, then cultured in the bioreactor, which is separated by a semipermeable membrane (0.2 microm) from the lumen through which the patients' blood plasma was circulated. After post-hemoperfusion, patients' blood was obtained for screening. Additionally, samples of medium collected from both intraluminal and extraluminal compartments of the laboratory bioreactor and culture supernate in vitro was analyzed. The presence of viral sequences was estimated by polymerase chain reaction (PCR) and reverse transcriptase-polymerase chain reaction (RT-PCR). Finally, the infection of virus in the supernate of common culture was ascertained by exposure to the fetal liver cells.
RESULTS: PERV-specific gag sequences were found in the porcine hepatocytes using RT-PCR. and were detected in all samples from the intraluminal, extraluminal samples and culture supernate. However, culture supernatant from primary porcine hepatocytes (cleared of cellular debris) failed to infect human fetal liver cells. Finally, RT-PCR detected no PERV infection was found in the blood samples obtained from three patients at various times post-hemoperfusion.
CONCLUSION: The assays used are specific and sensitive, identified by second PCR. PERVs could be released from hepatocytes cultured in bioreactor without the stimulation of mitogen and could not be prevented by the hollow fiber semipermeable membrane, indicating the existence of PERV safety in extracorporeal bioartificial liver support system (EBLSS).

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16534887      PMCID: PMC4124445          DOI: 10.3748/wjg.v12.i8.1287

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Porcine endogenous retroviruses (PERVs): adaptation to human cells and attempts to infect small animals and non-human primates.

Authors:  J Denner; V Specke; J Schwendemann; S J Tacke
Journal:  Ann Transplant       Date:  2001       Impact factor: 1.530

2.  Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study.

Authors:  M P Chenard-Neu; K Boudjema; J Bernuau; C Degott; J Belghiti; D Cherqui; V Costes; J Domergue; F Durand; J Erhard; B De Hemptinne; G Gubernatis; A Hadengue; J Kemnitz; M McCarthy; H Maschek; G Mentha; K Oldhafer; B Portmann; M Praet; J Ringers; X Rogiers; L Rubbia; S Schalm; J P Bellocq
Journal:  Hepatology       Date:  1996-05       Impact factor: 17.425

3.  Early experiences with a porcine hepatocyte-based bioartificial liver in acute hepatic failure patients.

Authors:  E Morsiani; P Pazzi; A C Puviani; M Brogli; L Valieri; P Gorini; P Scoletta; E Marangoni; R Ragazzi; G Azzena; E Frazzoli; D Di Luca; E Cassai; G Lombardi; A Cavallari; S Faenza; A Pasetto; M Girardis; E Jovine; A D Pinna
Journal:  Int J Artif Organs       Date:  2002-03       Impact factor: 1.595

Review 4.  Auxiliary liver transplantation and bioartificial bridging procedures in treatment of acute liver failure.

Authors:  Karim Boudjema; Philippe Bachellier; Philippe Wolf; Jean-Daniel Tempé; Daniel Jaeck
Journal:  World J Surg       Date:  2001-12-21       Impact factor: 3.352

5.  Productive infection of a mink cell line with porcine endogenous retroviruses (PERVs) but lack of transmission to minks in vivo.

Authors:  V Specke; R Plesker; C Coulibaly; K Boller; J Denner
Journal:  Arch Virol       Date:  2002       Impact factor: 2.574

6.  Genetic alterations of the long terminal repeat of an ecotropic porcine endogenous retrovirus during passage in human cells.

Authors:  Joachim Denner; Volker Specke; Ulla Thiesen; Alexander Karlas; Reinhard Kurth
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

7.  Microchimerism and transmission of porcine endogenous retrovirus from a pig cell line or specific pathogen-free pig islets to mouse tissues and human cells during xenografts in nude mice.

Authors:  B Clémenceau; D Jégou; L Martignat; P Saï
Journal:  Diabetologia       Date:  2002-05-15       Impact factor: 10.122

8.  Development of a real time quantitative PCR assay for detection of porcine endogenous retrovirus.

Authors:  Takele Argaw; Armin Ritzhaupt; Carolyn A Wilson
Journal:  J Virol Methods       Date:  2002-10       Impact factor: 2.014

9.  Virus safety in xenotransplantation: first exploratory in vivo studies in small laboratory animals and non-human primates.

Authors:  V Specke; H J Schuurman; R Plesker; C Coulibaly; M Ozel; G Langford; R Kurth; J Denner
Journal:  Transpl Immunol       Date:  2002-05       Impact factor: 1.708

10.  Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells.

Authors:  Markus Irgang; Igor M Sauer; Alexander Karlas; Katrin Zeilinger; Jörg C Gerlach; Reinhard Kurth; Peter Neuhaus; Joachim Denner
Journal:  J Clin Virol       Date:  2003-10       Impact factor: 3.168

View more
  6 in total

1.  Future of bioartificial liver support.

Authors:  Robert Afm Chamuleau
Journal:  World J Gastrointest Surg       Date:  2009-11-30

2.  Influence of chitosan nanofiber scaffold on porcine endogenous retroviral expression and infectivity in pig hepatocytes.

Authors:  Bing Han; Xiao-Lei Shi; Jiang-Qiang Xiao; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 3.  Concise Review: Liver Regenerative Medicine: From Hepatocyte Transplantation to Bioartificial Livers and Bioengineered Grafts.

Authors:  Clara T Nicolas; Raymond D Hickey; Harvey S Chen; Shennen A Mao; Manuela Lopera Higuita; Yujia Wang; Scott L Nyberg
Journal:  Stem Cells       Date:  2016-10-02       Impact factor: 6.277

Review 4.  Bioartificial liver devices: Perspectives on the state of the art.

Authors:  Yi-Tao Ding; Xiao-Lei Shi
Journal:  Front Med       Date:  2010-11-19       Impact factor: 4.592

5.  Microbiological safety of a novel bio-artificial liver support system based on porcine hepatocytes: a experimental study.

Authors:  Bing Han; Xiao-Lei Shi; Yue Zhang; Xue-Hui Chu; Jin-Yang Gu; Jiang-Qiang Xiao; Hao-Zhen Ren; Jia-Jun Tan; Zhong-Ze Gu; Yi-Tao Ding
Journal:  Eur J Med Res       Date:  2012-05-25       Impact factor: 2.175

Review 6.  Porcine endogenous retroviruses in xenotransplantation--molecular aspects.

Authors:  Magdalena C Kimsa; Barbara Strzalka-Mrozik; Malgorzata W Kimsa; Joanna Gola; Peter Nicholson; Krzysztof Lopata; Urszula Mazurek
Journal:  Viruses       Date:  2014-05-13       Impact factor: 5.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.